Skip to main content
DongKook Life Science Co., Ltd. logo

DongKook Life Science Co., Ltd. — Investor Relations & Filings

Ticker · 303810 ISIN · KR7303810006 KO Manufacturing
Filings indexed 69 across all filing types
Latest filing 2025-07-09 Regulatory Filings
Country KR South Korea
Listing KO 303810

About DongKook Life Science Co., Ltd.

http://www.dkls.co.kr/eng/

DongKook Life Science Co., Ltd. is a specialized pharmaceutical company focused on diagnostic medicine and medical devices. The company develops, manufactures, and supplies a range of products with a core specialization in contrast media for medical imaging modalities such as X-ray and magnetic resonance imaging (MRI). In addition to its diagnostic pharmaceuticals, the company is involved in developing AI-powered medical technology. With a strong emphasis on research and development, DongKook Life Science focuses on technical innovation and the creation of new products, having successfully localized key diagnostic medicines for the market. The company serves a global customer base across numerous countries.

Recent filings

Filing Released Lang Actions
신규시설투자등
Regulatory Filings Classification · 100% confidence The document is a regulatory announcement regarding a new facility investment (CAPEX) by Dongkook Life Science. It details the investment amount, purpose (capacity expansion), and board approval. Since this relates to capital expenditure and investment in new facilities, it falls under the 'Capital/Financing Update' category.
2025-07-09 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a formal announcement regarding the scheduling and details of an Investor Relations (IR) event (기업설명회). It specifies the date, location, target audience, and purpose of the meeting. Since it is an announcement of an upcoming presentation rather than the presentation slides themselves, and it is a regulatory disclosure of an event, it fits the definition of a Regulatory Filing (RNS) or a notice of an event.
2025-06-20 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a formal announcement regarding an upcoming Investor Relations (IR) event (기업설명회). It provides details such as the date, time, location, target audience, and purpose of the meeting. Since it is an announcement of an event rather than the presentation slides themselves, and it is a short regulatory notice, it falls under the category of a general regulatory filing or announcement regarding corporate activities.
2025-05-23 Korean
분기보고서 (2025.03)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for Dongkook Life Science Co., Ltd. for the period ending March 31, 2025. It contains detailed financial information, business descriptions, shareholding structures, and management details, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2025
2025-05-15 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This type of filing is specifically used to report insider shareholdings and transactions by company directors or executives. In the provided taxonomy, 'Director's Dealing' (DIRS) is the correct category for reports detailing personal share transactions or ownership status by company directors and executives.
2025-04-08 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a formal regulatory filing submitted to the Financial Services Commission/Korea Exchange regarding the appointment or dismissal of outside directors (사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고). This falls under the category of board and management changes.
2025-03-21 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.